HEPARIN SODIUM
A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 2 efficacy supplement approvals on record.
- Product
- In this atlas
Overview
Technical summary
Drugs@FDA application NDA017651. Original approval 1978-02-10. Efficacy supplement approvals 1983-12-19, 1984-06-26. 4 products listed.
Trials at a glance
No registry trial in this atlas names this product.
- Regulatory decisions
- 3
Product details
- Type
- Medicine
- Model or formulation
- Dosage forms in the registry record: INJECTABLE
- Version
- Not stated in the openFDA record
Intended-use sources
No intended-use source is recorded.
The registry's words
Labels as the registry gives them, not rewritten.
- Application
- NDA017651
- Brand name
- HEPARIN SODIUM
- Applicant
- FRESENIUS KABI USA
- Active ingredient
- HEPARIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
Claims and evidence
Context FDA record read by the openFDA feed
- Recipient
- Recipient not specified
- Population
- Not stated in the openFDA record
- Care setting
- Not stated in the openFDA record
- Geography
- United States (a decision by the US Food and Drug Administration)
- Life stage
- Not stated in the openFDA record
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (regulatory decision)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
FDA records an approval of NDA017651 on 1978-02-10.
Applies to Recipient not specified FDA record read by the openFDA feed
- Certainty method
- Not assessed
- Limitations
- Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked
- Not recorded
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[26].submission_status_date
- How it applies
- The decision date as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- application_number
- How it applies
- The registry number of the record.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[26].submission_status
- How it applies
- The decision status as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
FDA records an approval of efficacy supplement 15 to NDA017651 on 1983-12-19.
Applies to Recipient not specified FDA record read by the openFDA feed
- Certainty method
- Not assessed
- Limitations
- Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked
- Not recorded
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[9].submission_status_date
- How it applies
- The decision date as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- application_number
- How it applies
- The registry number of the record.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[9].submission_status
- How it applies
- The decision status as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
FDA records an approval of efficacy supplement 16 to NDA017651 on 1984-06-26.
Applies to Recipient not specified FDA record read by the openFDA feed
- Certainty method
- Not assessed
- Limitations
- Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked
- Not recorded
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[31].submission_status_date
- How it applies
- The decision date as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- application_number
- How it applies
- The registry number of the record.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA017651 (openFDA record)
- Locator
- submissions[31].submission_status
- How it applies
- The decision status as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a52873488ee9f9204c90b1ad1e3ebcaeea7f366121cddc15bbeed28a4ceaddba- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
FDA label
The FDA label of the application holder, as the openFDA label dataset holds it, for this product.
No label from the application holder was found in the openFDA label dataset for application NDA017651. This page does not show another labeler's label in its place.
FDA decisions timeline
The regulatory decisions of the FDA that this atlas holds for this product, oldest first. Each links to its full record.
Authorization
Regulatory decision: HEPARIN SODIUM
- Not stated in the openFDA record
- Not stated in the openFDA record
- United States (a decision by the US Food and Drug Administration)
- Not stated in the openFDA record
- Gestational age Not reported
- Postnatal age Not reported
- Authority
- U.S. Food and Drug Administration
- Decision
- Approval,
- Pathway
- NDA
- Submission
NDA017651- Jurisdictions
- United States
- Product version
- Original application
- Indication
- Not stated in the openFDA record
- Basis
- FDA records an approval of NDA017651 on 1978-02-10.
Limitations. Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
Regulatory decision: HEPARIN SODIUM
- Not stated in the openFDA record
- Not stated in the openFDA record
- United States (a decision by the US Food and Drug Administration)
- Not stated in the openFDA record
- Gestational age Not reported
- Postnatal age Not reported
- Authority
- U.S. Food and Drug Administration
- Decision
- Supplemental approval,
- Pathway
- NDA
- Submission
NDA017651- Jurisdictions
- United States
- Product version
- Efficacy supplement 15
- Indication
- Not stated in the openFDA record
- Basis
- FDA records an approval of efficacy supplement 15 to NDA017651 on 1983-12-19.
Limitations. Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
Regulatory decision: HEPARIN SODIUM
- Not stated in the openFDA record
- Not stated in the openFDA record
- United States (a decision by the US Food and Drug Administration)
- Not stated in the openFDA record
- Gestational age Not reported
- Postnatal age Not reported
- Authority
- U.S. Food and Drug Administration
- Decision
- Supplemental approval,
- Pathway
- NDA
- Submission
NDA017651- Jurisdictions
- United States
- Product version
- Efficacy supplement 16
- Indication
- Not stated in the openFDA record
- Basis
- FDA records an approval of efficacy supplement 16 to NDA017651 on 1984-06-26.
Limitations. Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
Record details
- Record id
cardio:fdaprod-nda017651- Content hash
4295819d6479fe55344eec151dea83cf8cc6f9f961213afea910cd6bd8e79756